Hap Trading, LLC Biogen Inc. Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $160,046 - $194,460	634 Added 2.36%	27,549 $7.63 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.91 Million - $2.63 Million	9,814 Added 57.39%	26,915 $7.19 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $634,635 - $754,699	3,384 Added 24.67%	17,101 $3.49 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $1.18 Million - $1.49 Million	-6,096 Reduced 30.77%	13,717 $2.89 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $6.2 Million - $7.96 Million	-27,672 Reduced 58.28%	19,813 $4.75 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $2.68 Million - $3.5 Million	9,484 Added 24.96%	47,485 $13.4 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $4.17 Million - $6.67 Million	16,084 Added 73.39%	38,001 $13.2 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $9,960 - $11,669	-41 Reduced 0.19%	21,917 $6.13 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $3.37 Million - $5.07 Million	-14,252 Reduced 39.36%	21,958 $5.38 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $7.87 Million - $8.83 Million	36,210 New	36,210 $8.43 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.